16-10-2026 22:10 via medpagetoday.com

OTC Alpha-Agonist Drops for Eye Redness Get FDA Green Light

(MedPage Today) -- The FDA announced approval of apraclonidine ophthalmic solution 0.125% (Brytly) as an over-the-counter treatment for eye redness related to minor irritations.
The approval specifies use of the topical agent by adults and children...
Read more »

Medical Industry news



Adult ADHD; Encouraging Advance Care Planning; Hospital Closures in the U.S.
Healthcare Is Still on the Ballot. But the Debate Has Changed.
Iowa Faces a Reckoning Over Water Quality and Cancer Rates in Midterm Campaigns
PAs Hoping to Ease State Restrictions on Their Practice in 2027
ACOG Guideline Backs Early Hormone Therapy for Menopause Symptoms
Were Benzos Linked to Birth Defects?
Improving Survival for Adults With Sickle Cell Disease
First At-Home Thyroid Eye Disease Shot Approved
Subcutaneous Risankizumab Induction Improved Outcomes in Crohn's Disease
Keytruda Biosimilar Advances; Oncologist Turned Patient; Will AI Cure Cancer?
Medical Societies Start Pushing Back on RFK Jr.
Spontaneous Abortion Risk Higher With Some Migraine Drugs, U.S. Study Shows
Trump’s Grandkid Has Surgery; Doc's Execution Won't Be Streamed; Inside Plague Labs
Letters With 'Suspicious Substances' Sent to Congressional, Election Offices
Desktop versie